Localization of the α-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies

Strieter, 1995, The functional role of the ELR motif in CXC chemokine-mediated angiogenesis, J Biol Chem, 270, 27348, 10.1074/jbc.270.45.27348 Bleul, 1996, The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry, Nature, 382, 829, 10.1038/382829a0 Ding, 2000, Regulation of chemokine-induced transendothelial migration of T lymphocytes by endothelial activation: differential effects on naı̈ve and memory T cells, J Leukoc Biol, 67, 825, 10.1002/jlb.67.6.825 Nagasawa, 1998, A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4, Adv Immunol, 71, 211, 10.1016/S0065-2776(08)60403-4 Gleichmann, 2000, Cloning and characterization of SDF-1γ, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system, Eur J Neurosc, 12, 1857, 10.1046/j.1460-9568.2000.00048.x Feng, 1996, HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor, Science, 272, 872, 10.1126/science.272.5263.872 Murdoch, 2000, CXCR4: chemokine receptor extraordinaire, Immunol Rev, 177, 175, 10.1034/j.1600-065X.2000.17715.x Volin, 1998, Chemokine receptor CXCR4 expression in endothelium, Biochem Biophys Res Commun, 242, 46, 10.1006/bbrc.1997.7890 Signoret, 1997, Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4, J Cell Biol, 139, 651, 10.1083/jcb.139.3.651 Förster, 1998, Intracellular and surface expression of the HIV-1 coreceptor CXCR4/Fusin on various leukocyte subsets: rapid internalization and recycling upon activation, J Immunol, 160, 1522, 10.4049/jimmunol.160.3.1522 Salcedo, 1999, Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells. In vivo neovascularization induced by stromal-derived factor-1α, Am J Pathol, 154, 1125, 10.1016/S0002-9440(10)65365-5 Feil, 1998, Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR4/Fusin) under the control of autocrine activity and exogenous cytokines, Biochem Biophys Res Commun, 247, 38, 10.1006/bbrc.1998.8499 Jinquan, 2000, CXC chemokine receptor 4 expression and stromal cell-derived factor-1α-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10, Immunology, 99, 402, 10.1046/j.1365-2567.2000.00954.x Nagase, 2000, Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation, J Immunol, 164, 5935, 10.4049/jimmunol.164.11.5935 Griggs, 1995, Inclusion body myositis and myopathies, Ann Neurol, 38, 705, 10.1002/ana.410380504 De Bleecker, 1995, Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies, Am J Pathol, 146, 1178 Berson, 1996, A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains, J Virol, 70, 6288, 10.1128/JVI.70.9.6288-6295.1996 Winkler, 1998, Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant, Science, 278, 389, 10.1126/science.279.5349.389 Nanki, 2000, Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium, J Immunol, 165, 6590, 10.4049/jimmunol.165.11.6590 Matthys, 2001, AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-α receptor-deficient mice, J Immunol, 167, 4686, 10.4049/jimmunol.167.8.4686 Katsuta, 2000, Interleukin-8 and SDF1-α mRNA expression in colonic biopsies from patients with inflammatory bowel disease, Am J Gastroenterol, 95, 3157 Shimoda, 1998, Interleukin-8 and hIRH (SDF1-a/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C, Hepatology, 28, 108, 10.1002/hep.510280116 Fedyk, 2001, Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing, J Immunol, 166, 5749, 10.4049/jimmunol.166.9.5749 Phillips, 2002, Activation of pertusis toxin-sensitive CXCL12 (SDF-1) receptor mediates transendothelial migration of T lymphocytes across lymph node high endothelial cells, Eur J Immunol, 32, 837, 10.1002/1521-4141(200203)32:3<837::AID-IMMU837>3.0.CO;2-Q Mitsui, 1997, Preferential subsarcolemmal localization of dystrophin and beta-dystroglycan mRNA in human skeletal muscle, J Neuropathol Exp Neurol, 56, 94, 10.1097/00005072-199701000-00010 Luck, 1998, In situ identification of neuronal nitric oxide synthase (NOS-I) mRNA in mouse and rat skeletal muscle, Neurosci Lett, 246, 77, 10.1016/S0304-3940(98)00237-7 Kitchen, 1997, CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus, J Virol, 71, 6928, 10.1128/JVI.71.9.6928-6934.1997 Hesselgesser, 1997, CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons, Curr Biol, 7, 112, 10.1016/S0960-9822(06)00055-8 Murdoch, 1999, Functional expression of chemokine receptor CXCR4 on human epithelial cells, Immunology, 98, 36, 10.1046/j.1365-2567.1999.00848.x Murdoch, 1999, CXC chemokine receptor expression on human endothelial cells, Cytokine, 11, 704, 10.1006/cyto.1998.0465 De Bleecker, 1999, Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies, Neuromuscul Disord, 9, 239, 10.1016/S0960-8966(98)00126-6 Gupta, 1998, Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines, J Biol Chem, 273, 4282, 10.1074/jbc.273.7.4282 De Bleecker, 2002, Differential expression of chemokines in inflammatory myopathies, Neurology, 58, 1779, 10.1212/WNL.58.12.1779 Confalonieri, 2000, Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies, J Neuropathol Exp Neurol, 59, 164, 10.1093/jnen/59.2.164 Bartolli, 2001, CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies, Acta Neuropathol (Berl), 102, 385, 10.1007/s004010100394 Han, 2001, TNF-α mediates SDF-1α-induced NF-κB activation and cytotoxic effects in primary astrocytes, J Clin Invest, 108, 425, 10.1172/JCI12629 Murakami, 1999, Inhibitory mechanism of the CXCR4 antagonist human immunodeficiency virus type 1 infection, J Virol, 73, 7489, 10.1128/JVI.73.9.7489-7496.1999 Bertolini, 2002, CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma, Cancer Res, 62, 3106